These immunologically “cold” phenotypes align with established mechanisms of immune resistance in melanoma, such as MHC class II downregulation via STAT1 silencing (25), PD-L1 induction through YAP activation in BRAFi-resistant contexts (26), and EMT-driven T cell exclusion mediated by ZEB1 (27). Here, ZEB1 is linked to melanoma.